Post by GSK

Published today, our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders. In 2025, we delivered another year of strong performance and R&D momentum. We’re looking forward to further driving growth in 2026 and accelerating our pipeline of new specialty medicines and vaccines. Take a look at the highlights ⤵️ 🔗 More information for investors and media: https://gsk.to/4sLv0or